FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer

Effectiveness of DNA cross-linking drugs in the treatment of bladder cancer suggests that bladder cancer cells may have harbored an insufficient cellular response to DNA cross-link damage, which will sensitize cells to DNA cross-linking agents. Cell sensitivity benefits from deficient DNA damage res...

Descripción completa

Detalles Bibliográficos
Autores principales: Panneerselvam, Jayabal, Park, Hwan Ki, Zhang, Jun, Dudimah, Fred Duafalia, Zhang, Piyan, Wang, Hong, Fei, Peiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419064/
https://www.ncbi.nlm.nih.gov/pubmed/22828653
http://dx.doi.org/10.4161/cc.21400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419064/
https://www.ncbi.nlm.nih.gov/pubmed/22828653
http://dx.doi.org/10.4161/cc.21400

Ejemplares similares